KQ Labs’ Post

After a productive networking break in the Great Room Foyer, we now have the “Medtech by the Numbers” Panel Session, moderated by Jennifer McMahon, Partner at Seroba.: • Inga D. Deakin, Principal, Molten Ventures • Megan MacDonagh, Vice President, SV Health Investors • Anne Portwich, Partner, EQT Life Sciences  • Sylvain Sachot, Partner, Asabys Partners 2023 life science investment went down across the board, in biotech and medtech equally, but in diagnostics and healthtech to a greater degree. A panel of European VCs discusses what’s in store for 2024. The number of up-rounds is down, which is a negative for VC firms supporting early-stage companies. The situation needs to change in order to reward early investment, the lifeblood of medtech innovation. We are seeing a lot of structured deals, option deals with many milestones. It does look good when a strategic is interested in a company, and it provides a path for exit. But it is a two-sided sword.   Remain informed on new articles, conference updates and more with our helpful medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

I was excited to join the LifeArc Translational Science Summit yesterday to explore how I can support new companies scaling operations and improving efficiency to accelerate bringing medicines to market. A great opportunity for networking and staying current. #LifeArc #Consultancy #NetworkingOpportunity 🚀💼✨ 🔬 Biotech ventures morning sessions🔬 The UK’s biotech sector - Surveying the landscape and opportunities for growth  🌟 Claire Terlouw (LifeArc) and Steve Bates OBE FMedSci (BioIndustry Association (BIA)) led a discussion on the impact of the BIA within the life science sector. Hearing firsthand accounts of crisis management scenarios navigated through the BIA reaffirms its critical role in our industry. Successfully navigating challenges like the R&D tax credits debacle and the Silicon Valley Bank collapse is truly inspiring. #LifeArc #BIA #LifeScience 💡🔬 Financial Strategies for the future – funding innovative life science companies  🚀 We moved to the world of financing strategies. Led by Claire Terlouw (LifeArc) with Arthur Franken (Gilde Healthcare), Neil White (Yosemite), Eliot Charles (SR One Capital Management), and Luc Dochez (Droia Ventures). My key takeaways :   💼 Learning about diverse investor types, tailored investment strategies, and the crucial balance of risks in decision-making. From technical to financial considerations, every aspect matters.   💡 Embrace rejections as learning opportunities, building resilience for future success in the competitive investment landscape. #InvestmentStrategies #ResilienceBuilding 📈 The CEO war room   🌟 A session led by Imran Hamid (LifeArc) who was joined by Hakim Yadi (Closed Loop Medicine), Mike Westby (RQ Biotechnology Limited), and Natalie Mount (Abingworth) who shared their war stories, lessons learned, and tips for aspiring entrepreneurs.  My key takeaways: 🚀 Embrace feedback..... even a 'no' decision will provide valuable learnings.  🤝 Understand the evolving role of the board and the importance of building trust and relationships. #EntrepreneurshipJourney #LessonsLearned #CEO #Feedback #Trust💡 I’ll share the afternoon sessions tomorrow! #LATSS2024 Great to see some familiar faces too Natalie Francis, Claudia Montiel Equihua, Nigel Huscroft, Ian Catchpole, Kathryn Chapman,

🔥 Ready to ignite biotech collaborations? 🌟 Dive into our mindmap with game-changing strategies to bridge the Industry-Academia Gap in Biotech. 🧬💡 🚀🌐 Shape the future with breakthrough research and entrepreneurial vision. 👩🔬💼

What are the best approaches for startups to build meaningful connections with investors and maximize warm introductions? In this clip, the panelists discuss the importance of warm introductions and relationship-building regarding fundraising. Panelists stressed that warm intros, facilitated by trusted advisors or board members, are far more effective than cold emails or lengthy pitches. They advised keeping email outreach concise—highlighting key details like fundraising goals and lead investors—while avoiding unnecessary complexity. Leveraging tools like LinkedIn to identify and tap into mutual connections can further open doors. In a tight-knit community like Medtech, the key takeaway is clear: fostering personal relationships and tailoring your approach is essential for successful investor engagement. To hear more from this incredible group of panelists tune into the full LSI Europe ‘24 panel "Light at the End of the Tunnel in Medtech Financing”, on our website and YouTube channel featuring: • Nick Pachuda (Moderator) — Precision Life Science Partners • Martin Omid A. — Anthro Ventures • Anita Watkins — Rex Health Ventures • Sean Morris — Cultivation Capital • Eman Namati — SpectraWAVE, Inc. - Want to attend our next event? LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

Did you know that S3E partner HiSeedTech is an official pledger for EIT Deep Tech Talent? Watch the short interview with our Project Coordinator, Claudia Barbosa, where she highlights how the S3E Start program is fostering #DeepTech research and innovation in Southern Europe 🇪🇺 🚀

Green Chemistry? Opportunity for investors ( both Startup as well as Scaleup ) to get to know more about this aspect of sustainable investing.

Who says panels can be done only seated? 😄 At the Zero One Hundred Conferences (PE & VC Platform) in Amsterdam today we can see this is not the case. When it comes to Strategic Investment in Longevity, investors don’t only talk the talk, but walk the walk. 💯 Moderated by Bill Liao (SOSV Investment), the panelists Alex Colville (age1), Amol Sarva (LifeX Ventures), Marc P. Bernegger(Maximon - The Longevity Company Builder) and Stephanie D.(Lifespan.io (Lifespan Extension Advocacy Foundation)) shared that: 📍Longevity has became a hot topic in the 12 months because there are more funds available for such opportunities; 📍There are many low hanging fruits for VCs in longevity and more will come in the near future; In conclusion, longevity is something everyone is interested in and the demand is massive. The future is bright. 💥 Thank you Zero One Hundred Conferences (PE & VC Platform) for having us here as media partners! #longevity #startupinvestors #conference

Fabulous to be on the investor panel for Mintz’s Life Sciences Pitch Event today, on yet another glorious fall day in Boston. ☀️🍁 (Although perhaps all meetings that start at 8am should come with good weather?) Key feedback shared by our panel: 🔹 Ensure your target market is clear - especially when the population for your relevant indication is highly heterogenous 🔹 Share your current assumptions about how your product may be used (e.g., chronically vs. episodically) and open questions 🔹 If you're exploring a range of commercial use cases, share how you anticipate prioritizing across them over time 🔹 If your GTM strategy requires you to displace heavily entrenched solutions and/or processes, share how you will enable these transitions 🔹 Note the specific set of milestones to be achieved with investment 🔹 Always include target timelines and potential paths to exit Thank you to the incredible lineup of entrepreneurs who pitched today, and please stay in touch! Thank you to Dean Farmer and Charlie C. for facilitating today's event. Thank you to panelists David Fogel, CPA, Ben Littauer (he/him), Molly Hoult, and Richard Wagner for your contributions. Great to meet you, and thank you for all of your help, Emily (Krasowski) Yanachkov and Diana Malkin. #lifesciences #pitchevent #investor #panel #boston

Day 2 of Jump into the future....today! Blue Ocean Revolution :) Yesterday we had great insights from Pierre Erwes of BioMar who shared about Impact funds, what investors look for from a pitch (acronym PTV), Christiaan Lensvelt of Aqua-Spark discussed with us the parameters/criteria when they choose a portfolio company to be part of their deals, Israel Pons from Pitch at the Beach® and ANGELS NEST "Network of Angel Investors" (Co-investing in Startups & Scaleups) talked about stories on how angel investing and co-investing works and of course we shared the Top 5 Trends in Impact Investments. Day 2 I will shared trends 6 - 10 :) Not too late to join us: https://lnkd.in/d7prfMy7 #blueocean #futuretrends #impactinvesting #goodmorning

With Atlantic Canada's COVE being home to DIANA and multiple dual-use innovative companies, I hope to see a growing number of Atlantic Canadian companies within the cohort for 2024.   NATO DIANA (Defence Innovation Accelerator for the North Atlantic) is gearing up for its second call for innovative companies. Last year, they received applications from over 1300 visionaries across the Alliance, with multiple Canadian companies brought into the first cohort.   DIANA focuses on dual-use applications—bridging the gap between civilian and military solutions. 44 companies joined their pilot cohort, gaining access to resources and networks that accelerated their businesses.   In two weeks, DIANA will unveil the new challenges on their website and LinkedIn. This year, they’re expanding to five Challenges, including their original three.   #DIANA #Innovation #AtlanticCanada #TechSolutions #GlobalImpact